Comorbidities and Vaccination
Cross-source consensus on Comorbidities and Vaccination from 1 sources and 6 claims.
1 sources · 6 claims
How it works
Benefits
Risks & contraindications
Comparisons
Where it comes from
Highlighted claims
- All analysed hospitalised patients had at least one pre-existing condition. — Risk factors for COVID-19 symptom severity across clinical categories among hospitalised patients in Kuala Lumpur, Malaysia: a prospective cohort study
- Hypertension and chronic kidney disease were the only comorbidities with statistically significant differences across severity categories. — Risk factors for COVID-19 symptom severity across clinical categories among hospitalised patients in Kuala Lumpur, Malaysia: a prospective cohort study
- Vaccination status was associated with severity category. — Risk factors for COVID-19 symptom severity across clinical categories among hospitalised patients in Kuala Lumpur, Malaysia: a prospective cohort study
- Sinovac first, second, or two-dose vaccination was associated with higher category 4 prevalence than BNT162b2 or ChAdOx1 nCoV-19. — Risk factors for COVID-19 symptom severity across clinical categories among hospitalised patients in Kuala Lumpur, Malaysia: a prospective cohort study
- Hypertension may worsen COVID-19 through inflammatory, immune, cardiovascular, blood-flow, oxygenation, and metabolic pathways. — Risk factors for COVID-19 symptom severity across clinical categories among hospitalised patients in Kuala Lumpur, Malaysia: a prospective cohort study
- Booster vaccination suggested possible benefit, but interpretation was limited by confounding and missing data. — Risk factors for COVID-19 symptom severity across clinical categories among hospitalised patients in Kuala Lumpur, Malaysia: a prospective cohort study